Page 269 - Assurance of Sterility for Sensitive Combination Products and Materials
P. 269

Index   247


              Drug-eluting beads (DEBs), 8–21  Functional equivalence, 122–124
               sterilization, 19–21            Functions, packaging systems
              Drug-eluting stents (DES) sterilization,   challenges, 94–95
                   16–19                         container types/definitions/dosage form,
              Drug product sterility, 40–41          88–90
              Dry heat sterilization, 210        medical device vs. pharmaceutical
               history, 26–27                        packaging, 83–87
              Dye penetration, 98–99             plastic selection-pharmaceutical and
                                                     medical device packaging, 91–93
              E                                  stability issues related to, 93–94
              Electron beam and x-ray radiation
                   sterilization, 240          G
              EMA documents, 222               Gas delivery, 32
              End-to-end sterility assurance, 242–243  GHTF, 88–90
              Engineering solutions, HCF suite/room   Gloves, 154
                   design                      Glucose control, postoperative, 153–154
               airflow and ventilation, 153–155  Good manufacturing practice (GMP), 82
               protection and barriers, 155–161  Gowns, 155
               traffic patterns, 155–161
              Environmental monitoring, 54–55  H
              Equipment qualification, 28      Health-care-associated infections (HAIs),
              Ethylene oxide (EO) sterilization, 210, 240  95–96
               history, 25                       causes, 135–136, 138
               Protection and barriers, HCF, 160  challenges, 240
              European Standards (EN), 222, 232–233  classification, 145–146
               EN 556-1, 233                     prevention, 140, 151
               EN 556-2, 235                     risk assessment
               terminal sterilization, 232–233     behavior, 149–161
              EU submission process                burden/impact of, 138–139
               CE-marking, for medical device,     engineering solutions, 152
                   227–228                         identification, 138
               market authorization, as medicinal   patient-related factors, 137–149
                   product, 226–227                procedural interventions, 151–152
               regulatory classification, 225–226  procedural-related characteristics,
              Evaluation of medicinal products (EMA)   144–145
                   guidance, 222                   risk factors, 137
              Extractables and leachables, 104     transmission-based isolation
                                                     precautions, 150–151
              F                                    WHO “Safe Surgery Saves Lives”
              Facial protection, 153–154             initiative, 148
              First air principles, 52–53        sterilization cycle time, 155
              Food and Drug Administration (FDA)   surgical site infections (SSIs), 136
                   guidance, 31                  types, 135–136, 146
               feedback, 223–225               Health-care personnel attire, 151
               on labeling devices as sterile, 228–231  Health-care products classification, 1
               methods of sterilization, 229–230  Health-care professionals (HCPs) and
               510(k) submission, 230–231            caregivers, 206
              Forming, 107–109                 Heat exposure, 42–43
   264   265   266   267   268   269   270   271   272   273   274